MN-001

MN-001 is an anti-inflammatory agent. In vivo, MN-001 (10, 30, and 50 mg/kg) reduces the frequency of bladder voids, increases the intercontractile interval, and decreases the number of non-voiding contractions in a rat model of bladder hyperactivity induced by ovalbumin-induced mast cell stimulation.Formal Name: 4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]-butanoic acid. CAS Number: 125961-82-2. Synonyms: KCA 757, Tipelukast. Molecular Formula: C29H38O7S. Formula Weight: 530.7. Purity: >98%. Formulation: (Request formulation change), A solid. Solubility: Chloroform: slightly, Ethanol: 1 mg/ml, Ethyl Acetate: Slightly. lambdamax: 216, 252, 311 nm. SMILES: CC(C1=CC=C(OCCCSC(C=CC(C(C)=O)=C2O)=C2CCC)C(CCC)=C1OCCCC(O)=O)=O. InChi Code: InChI=1S/C29H38O7S/c1-5-9-23-25(14-12-22(20(4)31)29(23)36-16-7-11-27(32)33)35-17-8-18-37-26-15-13-21(19(3)30)28(34)24(26)10-6-2/h12-15,34H,5-11,16-18H2,1-4H3,(H,32,33). InChi Key: KPWYNAGOBXLMSE-UHFFFAOYSA-N.